Nitroglycerin: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
No edit summary
 
Line 1: Line 1:
[[File:Nobel_patent.jpg|Nobel's patent for nitroglycerin|thumb]]
[[File:Nitroglycerin_Synthesis_V.1.svg|Synthesis of nitroglycerin|thumb]]
[[File:Nitro.JPG|Nitroglycerin|thumb]]
'''Nitroglycerin''' ([[C3H5N3O9]]), also known as glyceryl trinitrate (GTN), is a chemical compound used for the management and treatment of [[angina pectoris]], [[heart failure]], and [[myocardial infarction]]. It is a potent vasodilator, expanding blood vessels and increasing the supply of blood and oxygen to the heart while reducing its workload.
'''Nitroglycerin''' ([[C3H5N3O9]]), also known as glyceryl trinitrate (GTN), is a chemical compound used for the management and treatment of [[angina pectoris]], [[heart failure]], and [[myocardial infarction]]. It is a potent vasodilator, expanding blood vessels and increasing the supply of blood and oxygen to the heart while reducing its workload.


Line 25: Line 28:
==Contraindications==
==Contraindications==
Nitroglycerin should not be used in patients with severe anemia, closed-angle glaucoma, or those taking phosphodiesterase inhibitors (e.g., sildenafil), as the combination can lead to severe hypotension.
Nitroglycerin should not be used in patients with severe anemia, closed-angle glaucoma, or those taking phosphodiesterase inhibitors (e.g., sildenafil), as the combination can lead to severe hypotension.
==Conclusion==
Nitroglycerin remains a cornerstone in the treatment of angina and other cardiovascular conditions due to its potent vasodilatory effects. Its ability to improve blood flow to the heart muscle while reducing the heart's workload makes it invaluable in acute and chronic management of heart disease.
[[Category:Pharmacology]]
[[Category:Pharmacology]]
[[Category:Cardiovascular system drugs]]
[[Category:Cardiovascular system drugs]]
[[Category:Nitrovasodilators]]
[[Category:Nitrovasodilators]]
{{Pharmacology-stub}}
{{Cardiovascular system drug-stub}}
{{Cardiovascular system drug-stub}}
<gallery>
File:Nobel_patent.jpg|Nobel's patent for nitroglycerin
File:Nitroglycerin_Synthesis_V.1.svg|Synthesis of nitroglycerin
File:Nitro.JPG|Nitroglycerin
</gallery>
<gallery>
File:Nobel patent.jpg|Nobel patent
File:Nitroglycerin Synthesis V.1.svg|Nitroglycerin Synthesis
File:Nitro.JPG|Nitroglycerin
</gallery>

Latest revision as of 02:40, 22 March 2025

Nobel's patent for nitroglycerin
Synthesis of nitroglycerin
Nitroglycerin

Nitroglycerin (C3H5N3O9), also known as glyceryl trinitrate (GTN), is a chemical compound used for the management and treatment of angina pectoris, heart failure, and myocardial infarction. It is a potent vasodilator, expanding blood vessels and increasing the supply of blood and oxygen to the heart while reducing its workload.

History[edit]

Nitroglycerin was first synthesized in 1847 by Italian chemist Ascanio Sobrero by adding glycerol to a mixture of nitric and sulfuric acid. Initially, its explosive properties were of more interest, but by the late 19th century, its therapeutic potential for angina was discovered by William Murrell, marking the beginning of its medical use.

Pharmacology[edit]

Nitroglycerin works by releasing nitric oxide (NO), which relaxes smooth muscle cells in the blood vessel walls, primarily in the veins, arteries, and large coronary arteries. This process, known as vasodilation, leads to a decrease in venous return and arterial pressure, reducing the heart's workload and oxygen demand.

Mechanism of Action[edit]

Upon administration, nitroglycerin is converted to nitric oxide (NO), a signaling molecule that activates guanylate cyclase in smooth muscle cells. This activation increases cyclic guanosine monophosphate (cGMP) levels, leading to smooth muscle relaxation and vasodilation.

Administration[edit]

Nitroglycerin can be administered in several forms, including sublingual tablets, transdermal patches, topical ointments, and intravenous infusions. The choice of administration depends on the condition being treated, the required speed of onset, and the duration of action needed.

Clinical Uses[edit]

Nitroglycerin is primarily used in the management of:

Side Effects[edit]

Common side effects include headache, dizziness, and hypotension. Orthostatic hypotension can occur, leading to an increased risk of falls, especially in the elderly. Tolerance to nitroglycerin can develop with long-term use, necessitating a nitrate-free period to restore sensitivity.

Contraindications[edit]

Nitroglycerin should not be used in patients with severe anemia, closed-angle glaucoma, or those taking phosphodiesterase inhibitors (e.g., sildenafil), as the combination can lead to severe hypotension.



Stub icon
   This article is a Cardiovascular system drug-related stub. You can help WikiMD by expanding it!